Varma Vibha, Mehta Naimish, Kumaran Vinay, Nundy Samiran
Department of Surgical Gastroenterology and Liver Transplantation, Sir Ganga Ram Hospital Room No. 2221, SSR Block, Rajinder Nagar, New Delhi 110060, India.
Int J Hepatol. 2011;2011:121862. doi: 10.4061/2011/121862. Epub 2011 Oct 5.
Patients with chronic liver disease and certain patients with acute liver failure require liver transplantation as a life-saving measure. Liver transplantation has undergone major improvements, with better selection of candidates for transplantation and allocation of scarce deceased donor organs (according to more objective criteria). Living donor liver transplantation came into existence to overcome the shortage of donor organs especially in countries where there was virtually no deceased donor programme. Advances in the technical aspects of the procedure, the intraoperative and postoperative care of both recipients and donors, coupled with the introduction of better immunosuppression protocols, have led to graft and patient survivals of over 90% in most high volume centres. Controversial areas like transplantation in alcoholic liver disease without abstinence, acute alcoholic hepatitis, and retransplantation for recurrent hepatitis C virus infection require continuing discussion.
慢性肝病患者和某些急性肝衰竭患者需要进行肝移植作为挽救生命的措施。肝移植已经取得了重大进展,在移植候选人的选择和稀缺的已故供体器官分配方面(依据更客观的标准)有了改进。活体供肝移植应运而生,以克服供体器官短缺的问题,尤其是在那些几乎没有已故供体项目的国家。该手术技术方面的进展、受体和供体的术中及术后护理,再加上引入了更好的免疫抑制方案,使得大多数大容量中心的移植物和患者生存率超过了90%。像在未戒酒的酒精性肝病、急性酒精性肝炎中进行移植以及因丙型肝炎病毒感染复发而再次移植等有争议的领域仍需持续讨论。